Barlogie B - Search Results

1

Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma.

Sawyer JR, Tian E, Shaughnessy JD Jr, Epstein J, Swanson CM, Stangeby C, Hale CL, Parr L, Lynn M, Sammartino G, Lukacs JL, Stein C, Bailey C, Zangari M, Davies FE, Van Rhee F, Barlogie B, Morgan GJ. Sawyer JR, et al. Among authors: barlogie b. Leukemia. 2017 Mar;31(3):637-644. doi: 10.1038/leu.2016.253. Epub 2016 Oct 3. Leukemia. 2017. PMID: 27694925 Free PMC article.

2

Cytogenetic findings in 200 patients with multiple myeloma.

Sawyer JR, Waldron JA, Jagannath S, Barlogie B. Sawyer JR, et al. Among authors: barlogie b. Cancer Genet Cytogenet. 1995 Jul 1;82(1):41-9. doi: 10.1016/0165-4608(94)00284-i. Cancer Genet Cytogenet. 1995. PMID: 7627933

3

Deletion of the retinoblastoma gene in multiple myeloma.

Dao DD, Sawyer JR, Epstein J, Hoover RG, Barlogie B, Tricot G. Dao DD, et al. Among authors: barlogie b. Leukemia. 1994 Aug;8(8):1280-4. Leukemia. 1994. PMID: 8057662

4

High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH.

Shaughnessy J, Tian E, Sawyer J, Bumm K, Landes R, Badros A, Morris C, Tricot G, Epstein J, Barlogie B. Shaughnessy J, et al. Among authors: barlogie b. Blood. 2000 Aug 15;96(4):1505-11. Blood. 2000. PMID: 10942398 Free article.

5

Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma.

Sawyer JR, Lukacs JL, Thomas EL, Swanson CM, Goosen LS, Sammartino G, Gilliland JC, Munshi NC, Tricot G, Shaughnessy JD Jr, Barlogie B. Sawyer JR, et al. Among authors: barlogie b. Br J Haematol. 2001 Jan;112(1):167-74. doi: 10.1046/j.1365-2141.2001.02546.x. Br J Haematol. 2001. PMID: 11167798 Free article.

6

Developmental therapeutics for multiple myeloma--a road map for the future.

Shaughnessy JD, Barlogie B. Shaughnessy JD, et al. Among authors: barlogie b. Semin Hematol. 2001 Jul;38(3):295-7. doi: 10.1016/s0037-1963(01)90022-8. Semin Hematol. 2001. PMID: 11486318 No abstract available.

7

Suppression of abnormal karyotype predicts superior survival in multiple myeloma.

Arzoumanian V, Hoering A, Sawyer J, van Rhee F, Bailey C, Gurley J, Shaughnessy JD Jr, Anaissie E, Crowley J, Barlogie B. Arzoumanian V, et al. Among authors: barlogie b. Leukemia. 2008 Apr;22(4):850-5. doi: 10.1038/sj.leu.2405091. Epub 2008 Jan 17. Leukemia. 2008. PMID: 18200039 Free PMC article.

8

VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myeloma.

Pineda-Roman M, Zangari M, van Rhee F, Anaissie E, Szymonifka J, Hoering A, Petty N, Crowley J, Shaughnessy J, Epstein J, Barlogie B. Pineda-Roman M, et al. Among authors: barlogie b. Leukemia. 2008 Jul;22(7):1419-27. doi: 10.1038/leu.2008.99. Epub 2008 Apr 24. Leukemia. 2008. PMID: 18432260 Free PMC article. Clinical Trial.

9

The molecular characterization and clinical management of multiple myeloma in the post-genome era.

Zhou Y, Barlogie B, Shaughnessy JD Jr. Zhou Y, et al. Among authors: barlogie b. Leukemia. 2009 Nov;23(11):1941-56. doi: 10.1038/leu.2009.160. Epub 2009 Aug 6. Leukemia. 2009. PMID: 19657360 Free PMC article. Review.

10

Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma.

Heuck CJ, Qu P, van Rhee F, Waheed S, Usmani SZ, Epstein J, Zhang Q, Edmondson R, Hoering A, Crowley J, Barlogie B. Heuck CJ, et al. Among authors: barlogie b. Leukemia. 2014 Dec;28(12):2410-3. doi: 10.1038/leu.2014.232. Epub 2014 Jul 31. Leukemia. 2014. PMID: 25079174 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

697 results

Search Page

Filters